Melanoma in situ, also known as stage 0 melanoma, was diagnosed.  The patient presents with a clinically atypical melanocytic lesion concerning for melanoma.  Dermoscopic examination revealed features suspicious for melanoma in situ, including irregular borders, asymmetry, and variations in color.  The lesion, measuring [measurement] mm in diameter, is located on the [location of lesion].  No palpable lymphadenopathy was noted on physical examination.  The patient denies personal or family history of melanoma.  Differential diagnoses considered included atypical nevus, lentigo maligna, and seborrheic keratosis.  A shave biopsy or excisional biopsy was performed and submitted for histopathological examination.  Pathology report confirms the diagnosis of melanoma in situ, demonstrating atypical melanocytes confined to the epidermis with no invasion into the dermis.  Surgical margins are [positive, negative, or close].  Based on these findings, complete excision with [margin size] margins is recommended.  Patient education was provided regarding melanoma prevention, including sun protection strategies and regular skin self-exams.  Follow-up is scheduled in [timeframe] for surveillance and monitoring.  ICD-10 code D03.70 is used for malignant melanoma in situ of unspecified site, and CPT codes for biopsy and excision will be determined based on the procedure performed.  This documentation supports medical necessity for the procedures and facilitates accurate medical billing and coding.